Reduced interferon antagonism but similar drug sensitivity in Omicron variant compared to Delta variant of SARS-CoV-2 isolates

Cell Res. 2022 Mar;32(3):319-321. doi: 10.1038/s41422-022-00619-9. Epub 2022 Jan 21.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antiviral Agents / pharmacology
  • Antiviral Agents / therapeutic use
  • COVID-19 Drug Treatment*
  • Humans
  • Interferons
  • SARS-CoV-2*

Substances

  • Antiviral Agents
  • Interferons

Supplementary concepts

  • SARS-CoV-2 variants